Targeted therapies for triple-negative breast cancer: combating a stubborn disease
Triple-negative breast cancers (TNBCs) constitute a heterogeneous subtype of breast
cancers that have a poor clinical outcome. Although no approved targeted therapy is …
cancers that have a poor clinical outcome. Although no approved targeted therapy is …
Targeting the cell cycle in breast cancer: towards the next phase
Deregulation of the cell cycle is a hallmark of cancer that enables limitless cell division. To
support this malignant phenotype, cells acquire molecular alterations that abrogate or …
support this malignant phenotype, cells acquire molecular alterations that abrogate or …
[HTML][HTML] DGCA: a comprehensive R package for differential gene correlation analysis
Background Dissecting the regulatory relationships between genes is a critical step towards
building accurate predictive models of biological systems. A powerful approach towards this …
building accurate predictive models of biological systems. A powerful approach towards this …
Mechanisms of genomic instability in breast cancer
Breast cancer is the most common cancer among women globally. Genomic instability (GI)
refers to the increased tendency to accrue genomic alterations. It drives heterogeneity and is …
refers to the increased tendency to accrue genomic alterations. It drives heterogeneity and is …
Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis
CEP55 was initially identified as a pivotal component of abscission, the final stage of
cytokinesis, serving to regulate the physical separation of two daughter cells. Over the past …
cytokinesis, serving to regulate the physical separation of two daughter cells. Over the past …
[HTML][HTML] Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model
ARR Maia, J de Man, U Boon, A Janssen, JY Song… - Annals of …, 2015 - Elsevier
Background Triple-negative breast cancers (TNBC) are considered the most aggressive
type of breast cancer, for which no targeted therapy exists at the moment. These tumors are …
type of breast cancer, for which no targeted therapy exists at the moment. These tumors are …
Effects of aneuploidy on gene expression: implications for cancer
M Dürrbaum, Z Storchová - The FEBS journal, 2016 - Wiley Online Library
Unbalanced chromosome content, so‐called aneuploidy, is a hallmark of cancer cells.
Changes in the copy numbers of chromosomes or large chromosomal regions significantly …
Changes in the copy numbers of chromosomes or large chromosomal regions significantly …
CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer
The centrosomal protein, CEP 55, is a key regulator of cytokinesis, and its overexpression is
linked to genomic instability, a hallmark of cancer. However, the mechanism by which it …
linked to genomic instability, a hallmark of cancer. However, the mechanism by which it …
Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
Epithelial ovarian carcinoma (EOC) patients often acquire resistance against common
chemotherapeutic drugs like paclitaxel and cisplatin. The mechanism responsible for the …
chemotherapeutic drugs like paclitaxel and cisplatin. The mechanism responsible for the …
[HTML][HTML] Druggable molecular targets for the treatment of triple negative breast cancer
M Nakhjavani, JE Hardingham… - Journal of breast …, 2019 - synapse.koreamed.org
Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the
subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient …
subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient …